InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Enrique Poradosu, Chief Science & Business Off, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 6 open-market SEC Form 4 transactions: 6 purchases worth $40K and 0 sales worth $0, reported from Feb 4, 22 to Nov 19, 24. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 19, 24 | NVCTNuvectis Pharma, Inc. | BUY | 2.0K | $4.99 | $10K |
| May 10, 24 | NVCTNuvectis Pharma, Inc. | BUY | 500 | $6.29 | $3K |
| Mar 27, 23 | NVCTNuvectis Pharma, Inc. | BUY | 500 | $11.55 | $6K |
| May 12, 22 | NVCTNuvectis Pharma, Inc. | BUY | 370 | $16.04 | $5K |
| Feb 7, 22 | NVCTNuvectis Pharma, Inc. | BUY | 800 | $3.88 | $3K |
| Feb 4, 22 | NVCTNuvectis Pharma, Inc. | BUY | 3.8K | $3.35 | $13K |